Insider Transactions in Q2 2021 at Standard Biotools Inc. (LAB)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 25
2021
|
Laura Clague Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,342
+17.88%
|
-
|
May 25
2021
|
Ana K. Stankovic Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,342
+35.78%
|
-
|
May 25
2021
|
Bill Colston Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,342
+26.71%
|
-
|
May 25
2021
|
Carlos V Paya Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,342
+12.94%
|
-
|
May 25
2021
|
Nicolas Barthelemy Director |
BUY
Grant, award, or other acquisition
|
Indirect |
10,342
+5.49%
|
-
|
May 25
2021
|
Gerhard F Burbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,342
+13.56%
|
-
|
May 20
2021
|
Colin Mc Cracken Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
36,087
-39.04%
|
$180,435
$5.52 P/Share
|
May 20
2021
|
Colin Mc Cracken Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
66,520
+14.86%
|
-
|
May 20
2021
|
Vikram Jog Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,939
-12.9%
|
$89,695
$5.52 P/Share
|
May 20
2021
|
Vikram Jog Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
51,878
+7.94%
|
-
|
May 20
2021
|
Nicholas Khadder SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
22,838
-23.56%
|
$114,190
$5.52 P/Share
|
May 20
2021
|
Nicholas Khadder SVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
46,250
+21.59%
|
-
|
May 20
2021
|
Stephen Christopher Linthwaite President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
89,329
-23.48%
|
$446,645
$5.52 P/Share
|
May 20
2021
|
Stephen Christopher Linthwaite President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
177,417
+9.72%
|
-
|
May 20
2021
|
Bradley Allen Kreger SVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
19,882
-20.61%
|
$99,410
$5.52 P/Share
|
May 20
2021
|
Bradley Allen Kreger SVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
57,752
+12.7%
|
-
|